Fresenius Medical Care Corporation (FMS)vsSyra Health Corp. Class A Common Stock (SYRA)
FMS
Fresenius Medical Care Corporation
$22.26
+1.04%
HEALTHCARE · Cap: $12.47B
SYRA
Syra Health Corp. Class A Common Stock
$0.18
0.00%
HEALTHCARE · Cap: $2.11M
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 271525% more annual revenue ($19.63B vs $7.23M). FMS leads profitability with a 5.0% profit margin vs -12.4%. FMS earns a higher WallStSmart Score of 62/100 (C+).
FMS
Buy62
out of 100
Grade: C+
SYRA
Avoid28
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+73.4%
Fair Value
$90.32
Current Price
$22.26
$68.06 discount
Intrinsic value data unavailable for SYRA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
4.2% earnings growth
Grey zone — moderate risk
ROE of 7.9% — below average capital efficiency
5.0% margin — thin
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -36.0% — below average capital efficiency
Revenue declined 13.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.73 suggests the stock is reasonably priced for its growth.
Bull Case : SYRA
The strongest argument for SYRA centers on Price/Book, Debt/Equity.
Bear Case : FMS
The primary concerns for FMS are EPS Growth, Altman Z-Score, Return on Equity. Thin 5.0% margins leave little buffer for downturns.
Bear Case : SYRA
The primary concerns for SYRA are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
FMS profiles as a value stock while SYRA is a turnaround play — different risk/reward profiles.
SYRA carries more volatility with a beta of 3.96 — expect wider price swings.
FMS is growing revenue faster at -0.3% — sustainability is the question.
FMS generates stronger free cash flow (564M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (62/100 vs 28/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →Syra Health Corp. Class A Common Stock
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Syra Health Corp. The company is headquartered in Carmel, Indiana.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?